Advertisement

Cell Biochemistry and Biophysics

, Volume 61, Issue 1, pp 73–81 | Cite as

Expression of the Integrin-Linked Kinase in a Rat Kidney Model of Chronic Allograft Nephropathy

  • Conghui Han
  • Hequn Zou
  • Qingqin Li
  • Yuxin WangEmail author
  • Yanling Shi
  • Tianyu Lv
  • Ling Chen
  • Wenying Zhou
Original Paper

Abstract

The purpose of this study was to investigate the expression and significance of integrin-linked kinase (ILK) in the pathogenesis of chronic allograft nephropathy (CAN) in rats. For this, kidneys of Fisher (F344) rats were orthotopically transplanted into Lewis (LEW) rats. The animals were evaluated at 4, 8, 12, 16, and 24 weeks post-transplantation for renal function and histopathology. ILK protein expression was determined by Western-blot and immunohistological assays, and mRNA by RT-PCR. Our data show that 24-h urinary protein excretion in CAN rats increased significantly at week 16 as compared with F344/LEW controls. Allografts showed markedly increased mononuclear cells infiltration and presented with severe interstitial fibrosis and tubular atrophy at 16 and 24 weeks. ILK expression (protein/mRNA) was upregulated in rat kidneys with CAN, and the increase became more significant over time after transplantation. ILK expression correlated significantly with 24-h urinary protein excretion, serum creatinine levels, tubulointerstitial mononuclear cells infiltration, smooth muscle cells (SMCs) migration in vascular wall, and interstitial fibrosis. Therefore, it was concluded that ILK overexpression was the key event that involved mononuclear cells infiltration and vascular SMCs migration at early stage, and interstitial fibrosis and allograft nephroangiosclerosis at later stage of CAN pathogenesis in rats.

Keywords

Integrin-linked kinase Chronic allograft nephropathy Interstitial fibrosis Vascular smooth muscle cells Nephroangiosclerosis 

Notes

Acknowledgments

The authors thank Xiongfei Gu for excellent technical support. This study was funded by Xiamen Research Grant.

References

  1. 1.
    Pilmore, H. L., Painter, D. M., Bishop, G. A., McCaughan, G. W., & Eris, J. M. (2000). Early up-regulation of macrophages and myodibribroblasts, a new marker for development of chronic renal allograft rejection. Transplantation, 69, 2658–2662.PubMedCrossRefGoogle Scholar
  2. 2.
    Lutz, J., Zou, H., Liu, S., Antus, B., & Heemann, U. (2003). Apoptosis and treatment of chronic allograft nephropathy with everolimus. Transplantation, 15, 508–815.CrossRefGoogle Scholar
  3. 3.
    Scholten, E. M., Rowshani, A. T., Cremers, S., Bemelman, F. J., Eikmans, M., van Kan, E., et al. (2006). Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. Journal of the American Society of Nephrology, 17, 2622–2632.PubMedCrossRefGoogle Scholar
  4. 4.
    Madhan, K. K., & Temple-Camp, C. R. (2009). Late de novo minimal change disease in a renal allograft. Saudi Journal of Kidney Diseases and Transplantation, 20, 266–269.PubMedGoogle Scholar
  5. 5.
    Song, E., Zou, H., Yao, Y., Proudfoot, A., Antus, B., Liu, S., et al. (2002). Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney International, 61, 676–685.PubMedCrossRefGoogle Scholar
  6. 6.
    Zou, H., Yao, J., Wang, Y., Wang, J., Li, D., & Wang, P. (2005). Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof. National Medical Journal of China, 85, 981–985.PubMedGoogle Scholar
  7. 7.
    Kogata, N., Tribe, R. M., Fässler, R., Way, M., & Adams, R. H. (2009). Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction. Genes and Development, 23, 2278–2283.PubMedCrossRefGoogle Scholar
  8. 8.
    Kim, G. W., Kim, H. J., Cho, K. J., Kim, H. W., Cho, Y. J., & Lee, B. I. (2009). The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus. Neurobiology of Diseases, 36, 169–180.CrossRefGoogle Scholar
  9. 9.
    Ding, L., Dong, L., Chen, X., Zhang, L., Xu, X., Ferro, A., et al. (2009). Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation, 120, 764–773.PubMedCrossRefGoogle Scholar
  10. 10.
    Fielding, A. B., & Dedhar, S. (2009). The mitotic functions of integrin-linked kinase. Cancer and Metastasis Reviews, 28, 99–111.PubMedCrossRefGoogle Scholar
  11. 11.
    Ho, B., & Bendeck, M. P. (2009). Integrin linked kinase (ILK) expression and function in vascular smooth muscle cells. Cell Adhesion & Migration, 3, 174–176.CrossRefGoogle Scholar
  12. 12.
    Yamazaki, T., Masuda, J., Omori, T., Usui, R., Akiyama, H., & Maru, Y. (2009). EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. Journal of Cell Science, 15, 243–255.CrossRefGoogle Scholar
  13. 13.
    Friedrich, E. B., Sinha, S., Li, L., Dedhar, S., Force, T., Rosenzweig, A., et al. (2002). Role of integrin-linked kinase in leukocyte recruitment. Journal of Biological Chemistry, 277, 16371–16375.PubMedCrossRefGoogle Scholar
  14. 14.
    Kaneko, Y., Kitazato, K., & Basaki, Y. (2004). Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. Journal of Cell Science, 117, 407–415.PubMedCrossRefGoogle Scholar
  15. 15.
    Sabattini, E., Bisgaard, K., Ascani, S., Poggi, S., Piccioli, M., Ceccarelli, C., et al. (1998). The EnVision++ system: A new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. Journal of Clinical Pathology, 51, 506–511.PubMedCrossRefGoogle Scholar
  16. 16.
    Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M., & Srivastava, D. (2004). Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432, 466–472.PubMedCrossRefGoogle Scholar
  17. 17.
    Tan, C., Cruet-Hennequart, S., Troussard, A., Fazli, L., Costello, P., Sutton, K., et al. (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell, 5, 79–90.PubMedCrossRefGoogle Scholar
  18. 18.
    Deng, J. T., Van Lierop, J. E., Sutherland, C., & Walsh, M. P. (2001). Ca2+-independent smooth muscle contraction, a novel function for integrin-linked kinase. Journal of Biological Chemistry, 276, 16365–16373.PubMedCrossRefGoogle Scholar
  19. 19.
    Troussard, A. A. (2000). The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene, 19, 5444–5452.PubMedCrossRefGoogle Scholar
  20. 20.
    Li, Y., Tan, X., Dai, C., Stolz, D. B., Wang, D., & Liu, Y. (2009). Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. Journal of the American Society of Nephrology, 20, 1907–1918.PubMedCrossRefGoogle Scholar
  21. 21.
    Burns, W. C., Kantharidis, P., & Thomas, M. C. (2007). The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs, 18, 222–231.CrossRefGoogle Scholar
  22. 22.
    Liu, Y. (2010). New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology, 21, 212–222.PubMedCrossRefGoogle Scholar
  23. 23.
    Kang, Y. S., Li, Y., Dai, C., Kiss, L. P., Wu, C., & Liu, Y. (2010). Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney International, 78, 363–373.PubMedCrossRefGoogle Scholar
  24. 24.
    Li, Y., Yang, J., Dai, C., Wu, C., & Liu, Y. (2003). Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. Journal of Clinical Investigation, 112, 503–516.PubMedGoogle Scholar
  25. 25.
    Shimizu, M., Kondo, S., Urushihara, M., Takamatsu, M., Kanemoto, K., Nagata, M., et al. (2006). Role of integrin-linked kinase in epithelial–mesenchymal transition in crescent formation of experimental glomerulonephritis. Nephrology, Dialysis, Transplantation, 21, 2380–2390.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Conghui Han
    • 1
  • Hequn Zou
    • 2
  • Qingqin Li
    • 3
  • Yuxin Wang
    • 3
    Email author
  • Yanling Shi
    • 4
  • Tianyu Lv
    • 3
  • Ling Chen
    • 5
  • Wenying Zhou
    • 5
  1. 1.Department of UrologyThe Affiliated Xuzhou Hospital of Southeast UniversityXuzhouChina
  2. 2.Department of NephrologyThe No.3 Affiliated Hospital of Southern Medical UniversityGuangzhouChina
  3. 3.Department of NephrologyThe 2nd Hospital of XiamenXiamenChina
  4. 4.Deptartment of NephrologyThe No.1 Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina
  5. 5.Department of NephrologyThe No.5 Affiliated Hospital of Sun Yet-Sen UniversityZhuhaiChina

Personalised recommendations